Filing Flows › Fresenius Medical Care AG (FMS) › Q3 2026 › vs Q2 2026
Fresenius Medical Care AG (FMS) Q3 2026 vs Q2 2026 (quarter over quarter)
Fresenius Medical Care AG's revenue rose $76.2M (+2%) from $4.9B in Q2 2026 to $4.9B in Q3 2026. The biggest changes: Healthcare services +$93.0M (+3%); Insurance contracts −$63.8M (-11%); Healthcare products +$22.7M (+2%). Operating margin 7.8% against 9.6% (-1.8 pts).
Fresenius Medical Care AG, Q3 2026: revenue $4.9B (+1% year over year), operating margin 7.8%, net earnings $160M, operating cash flow $798M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Operating margin | 7.8% | 9.6% | -1.8 pts |
| Net margin | 3.2% | 4.5% | -1.3 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Healthcare services | $3.3B | $3.2B | $93.0M | +3% |
| Healthcare products | $1.1B | $1.1B | $22.7M | +2% |
| Insurance contracts | $504M | $568M | −$63.8M | -11% |
| Revenue | $4.9B | $4.9B | $76.2M | +2% |
| Operating profit | $384M | $466M | −$81.8M | -18% |
| Costs & expenses | $4.6B | $4.4B | $158M | +4% |
| Pre-tax earnings | $303M | $383M | −$80.4M | -21% |
| Other expense, net | $81.5M | $82.9M | −$1.4M | -2% |
| Research & development | $41.4M | $39.6M | $1.8M | +4% |
| SG&A | $744M | $736M | $7.6M | +1% |
| Other operating costs | $3.8B | $3.6B | $149M | +4% |
| Net earnings | $160M | $218M | −$58.6M | -27% |
| Minority interests | $65.0M | $74.8M | −$9.8M | -13% |
| Income tax | $77.8M | $89.8M | −$12.0M | -13% |
Questions
How much did Fresenius Medical Care AG's revenue grow quarter over quarter in Q3 2026?
Fresenius Medical Care AG's revenue rose $76.2M (+2%) from $4.9B in Q2 2026 to $4.9B in Q3 2026.
What drove Fresenius Medical Care AG's revenue change in Q3 2026?
Healthcare services +$93.0M (+3%); Insurance contracts −$63.8M (-11%); Healthcare products +$22.7M (+2%).